Stroke Trial, Recruiting NCT07500480 Sponsor: University Hospital, Toulouse Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07500480
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who took part in and finished the GRASP-AGAIN study and showed improvement in hand function through the use of a nerve-activating device (NAP)
  • People who have weakness or reduced movement in one arm caused by a single stroke (either a blocked or bleeding blood vessel in the brain), confirmed by a brain scan
  • People whose stroke happened more than one month ago
  • People who have at least one of the following hand difficulties: unable to open the fingers to grip a glass using a full-hand grip without help from the other hand (while being able to hold it passively); OR unable to extend the thumb to pick up a spoon handle using a thumb-and-index-finger grip without help from the other hand (while being able to hold the object passively if placed there)
  • People who are already receiving care through the standard health system
  • People who are able to sit in a chair and stay focused for at least 1.5 hours
  • People who have freely given their written consent before enrolling in the study
  • People who are covered by a social security or health insurance scheme

Who may not be able to join:

  • People who are currently in labour or breastfeeding
  • People who are pregnant (confirmed through questioning or a blood test if needed)
  • People who have tightness or stiffness in the fingers or wrist that prevents the fingers from being opened passively
  • People whose arm movement is too limited to position the hand in front of the body at the midline while seated (confirm with trial site)
  • People who experience pain in the affected arm that interferes with completing the standardised gripping tasks
  • People with significant loss of sensation in the arm, based on a specific sensory assessment score falling below a set threshold (confirm with trial site)
  • People with severe difficulty understanding or producing language, based on a specific language assessment score (confirm with trial site)
  • People with a known condition affecting the ability to perform purposeful movements (apraxia), within the limits of their physical ability
  • People with a condition affecting awareness of one side of space, where a specific visual test shows a significant difference between the left and right sides
  • People whose finger or thumb muscles cannot be activated enough through electrical stimulation to perform gripping tasks, or where that stimulation is not tolerated
  • People who have a pacemaker
  • People with epilepsy that is not currently controlled
  • People with unstable heart or cardiovascular conditions, such as coronary artery disease, severely high blood pressure, or heart failure
  • People with a skin condition that would make it unsafe to apply surface electrodes
  • People currently enrolled in another research study that has an active exclusion period
  • People under legal guardianship or conservatorship
  • People who decline to sign the consent form
  • People for whom it is not possible to properly explain the study or ensure their understanding due to physical or psychological health difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 5 61 34 00 56

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
30 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Analysis of therapeutic adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov